Back to FDA Approvals 2004
Hylaform Plus
Generic Name: hylan B gelDate of Approval: October 13, 2004
Company: Inamed Corporation and Genzyme Corporation
Treatment for: Wrinkle Correction
 | ||||||||
Feedback for Hylaform
| ||||||||
The U.S. Food and Drug Administration (FDA) has approved Hylaform Plus (Hylan-B gel), a large particle size hyaluronic acid-based dermal filler that is indicated for the correction of moderate to severe facial wrinkles and folds.
Hylaform Plus was developed and is manufactured by Genzyme Corporation. Inamed is Genzyme's exclusive worldwide marketing and distribution partner for Hylaform Plus.
Hylaform Plus is a sterile, nonpyrogenic, viscoelastic, clear, colorless, transparent gel implant composed of cross-linked molecules of hyaluronan. Hyaluronan is a naturally occurring polysaccharide of the intercellular matrix in human tissues, including skin.
Hylaform Plus is injected into the dermal tissue to provide a space-occupying viscoelastic supplement for the intercellular matrix of the connective tissue. This viscosupplementation or augmentation of the dermal tissue can result in the correction of skin contour deformities caused by wrinkles or folds.
For more information, please visit www.inamed.com.
 |
Link to Page |  |
Print Page |  |
Email Page |  | Add to List |
Facial Lipoatrophy, Wrinkle Correction
